These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

299 related items for PubMed ID: 29475062

  • 1. Resveratrol suppresses doxorubicin-induced cardiotoxicity by disrupting E2F1 mediated autophagy inhibition and apoptosis promotion.
    Gu J, Fan YQ, Zhang HL, Pan JA, Yu JY, Zhang JF, Wang CQ.
    Biochem Pharmacol; 2018 Apr; 150():202-213. PubMed ID: 29475062
    [Abstract] [Full Text] [Related]

  • 2. Resveratrol-induced autophagy promotes survival and attenuates doxorubicin-induced cardiotoxicity.
    Gu J, Hu W, Song ZP, Chen YG, Zhang DD, Wang CQ.
    Int Immunopharmacol; 2016 Mar; 32():1-7. PubMed ID: 26774212
    [Abstract] [Full Text] [Related]

  • 3. AMP-activated protein kinase α2 and E2F1 transcription factor mediate doxorubicin-induced cytotoxicity by forming a positive signal loop in mouse embryonic fibroblasts and non-carcinoma cells.
    Yang W, Park IJ, Yun H, Im DU, Ock S, Kim J, Seo SM, Shin HY, Viollet B, Kang I, Choe W, Kim SS, Ha J.
    J Biol Chem; 2014 Feb 21; 289(8):4839-52. PubMed ID: 24398673
    [Abstract] [Full Text] [Related]

  • 4. Ghrelin inhibits doxorubicin cardiotoxicity by inhibiting excessive autophagy through AMPK and p38-MAPK.
    Wang X, Wang XL, Chen HL, Wu D, Chen JX, Wang XX, Li RL, He JH, Mo L, Cen X, Wei YQ, Jiang W.
    Biochem Pharmacol; 2014 Apr 01; 88(3):334-50. PubMed ID: 24522112
    [Abstract] [Full Text] [Related]

  • 5. A novel compound DT-010 protects against doxorubicin-induced cardiotoxicity in zebrafish and H9c2 cells by inhibiting reactive oxygen species-mediated apoptotic and autophagic pathways.
    Tang F, Zhou X, Wang L, Shan L, Li C, Zhou H, Lee SM, Hoi MP.
    Eur J Pharmacol; 2018 Feb 05; 820():86-96. PubMed ID: 29229534
    [Abstract] [Full Text] [Related]

  • 6. Resveratrol attenuates doxorubicin-induced cardiotoxicity in rats by up-regulation of vascular endothelial growth factor B.
    Tian W, Yang L, Liu Y, He J, Yang L, Zhang Q, Liu F, Li J, Liu J, Sumi S, Shen Y, Qi Z.
    J Nutr Biochem; 2020 May 05; 79():108132. PubMed ID: 30857673
    [Abstract] [Full Text] [Related]

  • 7. Activation of p62-NRF2 Axis Protects against Doxorubicin-Induced Ferroptosis in Cardiomyocytes: A Novel Role and Molecular Mechanism of Resveratrol.
    Yu W, Chen C, Xu C, Xie D, Wang Q, Liu W, Zhao H, He F, Chen B, Xi Y, Yan Y, Yu L, Cheng J.
    Am J Chin Med; 2022 May 05; 50(8):2103-2123. PubMed ID: 36309811
    [Abstract] [Full Text] [Related]

  • 8. Enhanced-autophagy by exenatide mitigates doxorubicin-induced cardiotoxicity.
    Lee KH, Cho H, Lee S, Woo JS, Cho BH, Kang JH, Jeong YM, Cheng XW, Kim W.
    Int J Cardiol; 2017 Apr 01; 232():40-47. PubMed ID: 28159361
    [Abstract] [Full Text] [Related]

  • 9. Carvedilol (CAR) combined with carnosic acid (CAA) attenuates doxorubicin-induced cardiotoxicity by suppressing excessive oxidative stress, inflammation, apoptosis and autophagy.
    Zhang QL, Yang JJ, Zhang HS.
    Biomed Pharmacother; 2019 Jan 01; 109():71-83. PubMed ID: 30396094
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Resveratrol attenuates doxorubicin-induced cardiomyocyte death via inhibition of p70 S6 kinase 1-mediated autophagy.
    Xu X, Chen K, Kobayashi S, Timm D, Liang Q.
    J Pharmacol Exp Ther; 2012 Apr 01; 341(1):183-95. PubMed ID: 22209892
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. miR-146a attenuates apoptosis and modulates autophagy by targeting TAF9b/P53 pathway in doxorubicin-induced cardiotoxicity.
    Pan JA, Tang Y, Yu JY, Zhang H, Zhang JF, Wang CQ, Gu J.
    Cell Death Dis; 2019 Sep 11; 10(9):668. PubMed ID: 31511497
    [Abstract] [Full Text] [Related]

  • 18. Nrf2 deficiency exaggerates doxorubicin-induced cardiotoxicity and cardiac dysfunction.
    Li S, Wang W, Niu T, Wang H, Li B, Shao L, Lai Y, Li H, Janicki JS, Wang XL, Tang D, Cui T.
    Oxid Med Cell Longev; 2014 Sep 11; 2014():748524. PubMed ID: 24895528
    [Abstract] [Full Text] [Related]

  • 19. Resveratrol attenuates doxorubicin-induced cardiomyocyte apoptosis in mice through SIRT1-mediated deacetylation of p53.
    Zhang C, Feng Y, Qu S, Wei X, Zhu H, Luo Q, Liu M, Chen G, Xiao X.
    Cardiovasc Res; 2011 Jun 01; 90(3):538-45. PubMed ID: 21278141
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.